Journal ArticleOPEN ACCESS

KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis

  • Peeters M
  • Oliner K
  • Price T
  • et al.
Annals of Oncology (2014) 25 ii5
DOI: 10.1093/annonc/mdu164.2
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

ESMO 16th World Congress on Gastrointestinal Cancer, 25–28 June 2014, Barcelona, Spain

Cite

CITATION STYLE

APA

Peeters, M., Oliner, K., Price, T., Cervantes, A., Sobrero, A., Ducreux, M., … Patterson, S. (2014). KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis. Annals of Oncology, 25, ii5. https://doi.org/10.1093/annonc/mdu164.2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free